VBLT - Vascular Biogenics Ltd (VBLT) CEO Dror Harats on Q2 2021 Results - Earnings Call Transcript
Vascular Biogenics Ltd (VBLT) Q2 2021 Earnings Conference Call August 16, 2021 08:30 AM ET Company Participants Dror Harats - Chief Executive Officer Amos Ron - Chief Financial Officer Conference Call Participants Etzer Darout - Guggenheim Securities Susan Chor - Oppenheimer & Co Ramakanth Swayampakula - H.C. Wainwright Soumit Roy - Jones Trading Presentation Operator Greetings. Welcome to VBL Therapeutics Second Quarter 2021 Financial Results and Update Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to the VBL team. Thank you. You may begin. Unidentified Company Representative Thank you. Good morning, everyone, and thank you for joining today's VBL Therapeutics second quarter 2021 financial results and corporate update. Leading the call will be Professor Dror Harats, Chief Executive Officer; and Amos
For further details see:
Vascular Biogenics Ltd (VBLT) CEO Dror Harats on Q2 2021 Results - Earnings Call Transcript